According to allegations raised in a recently filed product liability lawsuit, a Minnesota woman developed a unique eye injury from Elmiron, indicating that manufacturers of the bladder pain drug failed to adequately evaluate the potential side effects before it was introduced and sold to consumers. The lawsuit is pursuing claims against Janssen Pharmaceuticals, Ortho-McNeil Pharmaceuticals,…
In a new study published this month in Clinical Ophthalmology, researchers at Northwestern University report that Elmiron related maculopathy has a distinct signature that can be identified using multi modal imaging. Imaging confirming retinal damage is likely to provide compelling evidence in lawsuits filed by Elmiron users that their maculopathy was caused by the use…
Another Elmiron Lawsuit was recently filed on behalf of a New York woman who suffered unexpected vision impairment after taking the bladder pain drug. The lawsuit alleges the drug manufacturer withheld information from users and the medical community about the risk of permanent retinal damage associated with the interstitial cystitis treatment. The lawsuit filed in…
Amid growing concerns about the link between side effects of Elmiron and vision problems, Canadian health officials have announced new label warnings for the bladder medication, indicating it should not be used by any individuals with a history of any macular pathology. Elmiron (pentosan polysulfate sodium or PPS) is the only oral medication approved for…
Lawyers are pursuing financial compensation for individuals nationwide who have been left with permanent and debilitating vision problems that resulted from side effects of Elmiron, a prescription medication for treatment of interstitial cystitis or bladder pain syndrome. As a result of the drug makers’ failure to warn about the risk of permanent retina damage that…
